Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€340.10

€340.10

0.270%
0.9
0.270%
€413.82
 
05.07.24 / Tradegate WKN: 856584 / Symbol: HUM / Name: Humana / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Humana Inc. Stock

Humana Inc. gained 0.270% compared to yesterday.
The stock is an absolute favorite of our community with 24 Buy predictions and no Sell predictions.
As a result the target price of 413 € shows a positive potential of 21.43% compared to the current price of 340.1 € for Humana Inc..
For the coming years our community has positive and negative things to say abot the Humana Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Humana Inc. (Symbol: HUM) is a leading healthcare and wellness company headquartered in Louisville, Kentucky, specializing in offering a diversified range of health insurance, wellness programs, and managed care plans to individual, group, government, and military customers. With a strong commitment to providing personalized, affordable, and high-quality healthcare solutions, Humana emphasizes on simplifying access and meeting the evolving needs of its vast clientele through leveraging data analytics, technology, and innovation. As a publicly traded entity, Humana’s stock is listed on the New York Stock Exchange, and it forms part of the esteemed S&P 500 index, reflecting its significant impact and presence within the highly competitive healthcare sector.

Pros and Cons of Humana Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Humana Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Humana Inc. 0.270% -0.531% 1.688% -17.567% -18.404% -11.374% 45.714%
UnitedHealth Group Inc. -1.010% 0.187% -1.927% 3.652% -4.397% 32.005% 110.464%
Centene Corp. -0.840% -1.779% -4.080% 0.211% -7.440% -1.072% 36.959%
Cigna Corp. -2.710% -4.684% -2.776% 17.270% 11.208% 50.050% 106.805%

Comments

Prediction Buy
Perf. (%) 1.23%
Target price 366.990
Change
Ends at 26.06.25

Humana Inc. (NYSE: HUM) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $392.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 18.13%
Target price 328.749
Change
Ends at 25.04.25

Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Royal Bank of Canada from $415.00 to $353.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 17.56%
Target price 345.950
Change
Ends at 25.04.25

Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $415.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Show more

News

University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky: https://mms.businesswire.com/media/20240612803639/en/2158228/5/Humana_impact_in_KY_graphic_FINAL.jpg
University of Louisville Study Outlines Humana’s Economic and Community Impact on Kentucky


The University of Louisville’s College of Business recently released the results of a study that evaluated Humana’s economic and community impact on Kentucky.


This press release features